Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EPS8 signaling adaptor L1 (EPS8L1) is a cytoskeletal-associated signaling adapter protein related to EPS8, which is a substrate for the epidermal growth factor receptor (EGFR)[3][6]. EPS8L1 is part of a family of proteins that mediate signal transduction from receptor tyrosine kinases (RTKs) to the actin cytoskeleton, primarily through interaction with other proteins such as Abi1 and Sos-1, and is involved in actin remodeling and membrane ruffling in response to growth factor stimulation[1]. Like EPS8, EPS8L1 contains an SH3 (Src homology 3) domain and a conserved C-terminal region important for binding with F-actin, suggesting a role in cytoskeleton organization and dynamic cell structures[1][3]. However, the detailed function and physiological role of EPS8L1 remain incompletely determined. It is not currently recognized as a therapeutic target, and there are no known drugs or direct mechanistic interventions for this protein[3][6]. EPS8L1 is associated with genetic disorders such as fetal akinesia deformation sequence and may play a role in cancer biology, but it is not itself a clinical biomarker or target for drug therapy at this time[3][4]. Functional redundancy within the EPS8 protein family suggests that loss of EPS8L1 can be compensated by related proteins[1][3].
Not applicable; no drugs target EPS8L1 directly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EPS8 signaling adaptor L1 (EPS8L1).